SCHEMBL4849185

SCHEMBL4849185

CN(C)CCCOc1ccccc1C(=O)C=Cc1ccc(Cl)cc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.53
CYSLTR1 Q9Y271 1/20 0.46
MAPT P10636 5/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 4/20 0.45
KDM4E B2RXH2 2/20 0.45
MEN1 O00255 2/20 0.45
LMNA P02545 3/20 0.45
ATM Q13315 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
MAOB P27338 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
HRH1 P35367 1/20 0.43
BCHE P06276 1/20 0.43
ACHE P22303 1/20 0.43
KEAP1 Q14145 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846128 0.95 PTPN5 (0.54) PTPN5CYSLTR1MAPTALDH1A1SMN1; SMN2
SCHEMBL4849180 0.88 MAPT (0.51) PTPN5MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4855102 0.88 MAPT (0.51) PTPN5MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4846123 0.83 MAPT (0.52) PTPN5MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL4856209 0.83 MAPT (0.52) PTPN5MAPTALDH1A1SMN1; SMN2NPC1
SCHEMBL11166397 0.79 HTR1B (0.47) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL11166392 0.79 HTR1B (0.47) MAPTALDH1A1NPC1RAB9AKMT2A
SCHEMBL4851312 0.78 PDE4A (0.61) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL5915502 0.78 PTPN5 (0.59) PTPN5MAPTALDH1A1SMN1; SMN2POLB
SCHEMBL5915667 0.77 PTPN5 (0.54) PTPN5MAPTALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed